Abstract:Juechuang, a traditional Chinese herbal medicine, is originated from Rostellularia procumbens (L.) Nees. Many studies have shown that the ethyl acetate extract from Juechaung may inhibit platelet aggregation. However, the antiplatelet aggregation mechanism of Juechuang requires more systematic research. In this article, network pharmacology was used to explore the antiplatelet aggregation components and its antiplatelet aggregation mechanism. Different components were evaluated and screened by pharmacokinetic characteristics. The potential targets of active ingredients were predicted by a reverse pharmacophore matching method, and the targets were screened according to targets related to antiplatelet aggregation in the GeneCards database. Thus, an interaction network of component-target-pathway of Juechuang was generated using Cytoscape 3.2.1. software. Furthermore, the binding energy of relevant active components with key targets was calculated using a Lamarck genetic algorithm in the molecular docking calculations. Finally, the study identified 28 potentially active ingredients in Juechuang, providing further evidence that the active ingredients act on 277 targets, and 38 protein targets related to antiplatelet aggregation were screened. Through the Kyoto encyclopedia of genes and genome pathway enrichment analysis, we found that the mechanism of antiplatelet aggregation may be related to the Ras signaling pathway, platelet activation signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, etc. Via molecular docking of 2 targets, non-receptor tyrosine kinases(SRC) and MAPK were selected for molecular docking. By comparing the molecular docking results of Chinensinaphthol, Taiwanin E, Tuberculatin, Cycloeucalenol, and Justicidin B to the control drug, we found that those test molecules combined with targets and lead to high binding activity. These molecular docking results were also consistent with the literature values, and they helped identify the active ingredients and assured the reliability of the network analysis. This study may further provide a reference for the systematic study of the pharmacodynamic effect and the antiplatelet aggregation mechanism of Juechuang.

Platelet Aggregation Pathway Network-Based Approach for Evaluating Compounds Efficacy

Network pharmacology approaches for research of Traditional Chinese Medicines

A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds.

Study of Components and Mechanism of Juechuang Against Platelet Aggregation Based on Network Pharmacology

A comprehensive application: Molecular docking and network pharmacology for the prediction of bioactive constituents and elucidation of mechanisms of action in component-based Chinese medicine

A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components

Modeling Compound-Target Interaction Network of Traditional Chinese Medicines for Type II Diabetes Mellitus: Insight for Polypharmacology and Drug Design.

Insights Into The Inhibition And Mechanism Of Compounds Against Lps-Induced Pge(2) Production: A Pathway Network-Based Approach And Molecular Dynamics Simulations

Exploring the Ligand-Protein Networks in Traditional Chinese Medicine: Current Databases, Methods, and Applications

[Network Target: a Starting Point for Traditional Chinese Medicine Network Pharmacology].

Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology

Traditional Chinese Medicine Network Pharmacology: Theory, Methodology and Application.

Network target for screening synergistic drug combinations with application to traditional Chinese medicine

Drug–target Network and Polypharmacology Studies of a Traditional Chinese Medicine for Type II Diabetes Mellitus

Network Pharmacology-based Approaches Capture Essence of Chinese Herbal Medicines

Quantitative Modeling of Dose–response and Drug Combination Based on Pathway Network

Network Pharmacology Evaluation Method Guidance - Draft

SYSTCM: A systemic web platform for objective identification of pharmacological effects based on interplay of "traditional Chinese Medicine-components-targets"

NP-TCMtarget: a network pharmacology platform for exploring mechanisms of action of Traditional Chinese medicine

Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine

Current strategies and technologies for finding drug targets of active components from traditional Chinese medicine